Electrical Impedance Tomography-Based Prognostic Model for ARDS

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorXiaoJing Zou,MD

About this trial

This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.

Eligibility criteria

Qualifiers

Meet the new 2023 ARDS global definition;

Age 18-80 years

Disqualifiers

Expected death within 24 hours of screening;

Metastatic cancer (active malignancy with distant metastases);

Severe psychiatric disorders;

Pregnancy or postpartum status;

Trial design

Treatments tested in this trial

  • Not applicable- observational study

Treatment groups

625 Participants
are divided into 2 treatment groups

Sponsors and collaborators

XiaoJing Zou,MD

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor institution